Heterogeneity of Ovarian Cancer: Relationships Among Histological Group, Stage of Disease, Tumor Markers, Patient Characteristics, and Survival

REFERENCES

• Cancer Facts and Figures. American Cancer Society, Atlanta, GA 1999; 4
   Google Scholar
• Bast R.C., Jr., Boyer C.M., Xu F.J., , et al. Molecular Approaches to Prevention and Detection of Epithelial Ovarian Cancer. J. Cell. Biochem. 1995; 23: 219–222
   Google Scholar
• Russell P. Surface Epithelial-Stromal Tumors of the Ovary. Blaustein's Pathology of the Female Genital Tract, R.J. Kurman. 4th Ed., Springer-Verlag, New York 1994; 705–782
   Google Scholar
• Mok S.C.H., Bell D.A., Knapp R.C., , et al. Mutation of K-RAS Protooncogene in Human Ovarian Epithelial Tumors of Borderline Malignancy. Cancer Res. 1993; 53: 1489–1492
   PubMed Web of Science ®Google Scholar
• Teneriello M.G., Ebina M., Linnoila R.I., , et al. P53 and Ki-Ras Gene Mutations in Epithelial Ovarian Neoplasms. Cancer Res. 1993; 53: 3103–3108
   PubMed Web of Science ®Google Scholar
• Dodson M.K., Hartmann L.C., Cliby W.A., , et al. Comparison of Loss of Heterozygosity Patterns in Invasive Low Grade and High Grade Epithelial Ovarian Carcinomas. Cancer Res. 1993; 53: 4456–4460
   PubMed Web of Science ®Google Scholar
• Chenevix-Trench G., Kerr J., Hurst T. Analysis of Loss of Heterozygosity and KRAS2 Mutations in Ovarian Neoplasms: Clinicopathological Correlations. Genes Chromosom. Cancer 1997; 18: 75–83
   PubMed Web of Science ®Google Scholar
• Pieretti M., Cavalieri C., Conway P.S., , et al. Genetic Alterations Distinguish Different Types of Ovarian Tumors. Int. J. Cancer 1995; 64(6)434–440
   PubMed Web of Science ®Google Scholar
• Foulkes W.D., Black D., Stamp G.W.H., , et al. Very Frequent Loss of Heterozygosity Throughout Chromosome 17 in Sporadic Ovarian Carcinoma. Int. J. Cancer 1993; 54: 220–225
   PubMed Web of Science ®Google Scholar
• Kupryjanczyk J., Thor A.D., Beauchamp R., , et al. P53 Gene Mutations and Protein Accumulation in Human Ovarian Cancer. Proc. Natl Acad. Sci. USA 1993; 90: 4961–4965
   PubMed Web of Science ®Google Scholar
• Thomas B.D. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives: the Influence of Combined Oral Contraceptives on Risk of Neoplasms in Developing and Developed Countries. Contraception 1991; 43: 695–710
   PubMed Web of Science ®Google Scholar
• Negri E., Franceschi S., Tzonou A., , et al. Pooled Analysis of 3 European Case–Control Studies: I: Reproductive Factors and Risk of Epithelial Ovarian Cancer. Int. J. Cancer 1991; 49: 50–56
   PubMed Web of Science ®Google Scholar
• Whittemore A.S., Harris R., Itnyre J. Characteristics Relating to Ovarian Cancer Risk. Collaborative Analysis of 12 US Case–Control Studies. II: Invasive Epithelial Ovarian Cancers in White Women. Am. J. Epidemiol. 1992; 13: 1184–1203
   Google Scholar
• Whittemore A.S. Personal Characteristics Relating to Risk of Invasive Epithelial Ovarian Cancers in Older Women in the United States. Cancer 1993; 71: 558–565
   PubMed Web of Science ®Google Scholar
• Purdie D., Green A.B.C., , et al. Reproductive and Other Factors and Risk of Epithelial Ovarian Cancer: an Australian Case–Control Study. Int. J. Cancer 1995; 62: 678–684
   PubMed Web of Science ®Google Scholar
• Yancik R. Ovarian Cancer: Age Contrasts in Incidence, Histology, Disease Stage at Diagnosis, and Mortality. Cancer 1993; 71: 517–523
   PubMed Web of Science ®Google Scholar
• Risch H.A., Weiss N.S., Lyon J.L., , et al. Events of Reproductive Life and the Incidence of Epithelial Ovarian Cancer. Am. J. Epidemiol. 1983; 117: 128–139
   PubMed Web of Science ®Google Scholar
• Cramer D.W., Hutchison G.B., Welch W.R., , et al. Determinants of Ovarian Cancer Risk. I: Reproductive Experiences and Family History. J. Natl Cancer Inst. 1983; 71: 717–721
   PubMedGoogle Scholar
• Garg P.P., Kerlikowske K., Subak L., , et al. Hormone Replacement Therapy and the Risk of Epithelial Ovarian Carcinoma: a Meta-Analysis. Obstet. Gynecol. 1998; 92: 472–479
   PubMed Web of Science ®Google Scholar
• Hankinson S.E., Hunter D.J., Colditz G.A., , et al. Tubal Ligation, Hysterectomy, and Risk of Ovarian Cancer. A Prospective Study. J. Am. Med. Assoc. 1993; 270: 2813–2818
   PubMed Web of Science ®Google Scholar
• Miracle-McMahill H.L., Calle E.E., Kosinski A.S., , et al. Tubal Ligation and Fatal Ovarian Cancer in a Large Prospective Cohort Study. Am. J. Epidemiol. 1997; 145: 349–357
   PubMed Web of Science ®Google Scholar
• Risch H.A., Marrett L.D., Jain M. Differences in Risk Factors for Epithelial Ovarian Cancer by Histological Type. Am. J. Epidemiol. 1996; 144: 363–372
   PubMed Web of Science ®Google Scholar
• Warren W., Hovig E., Smith-Sorensen B., , et al. Detection of Mutations by Single-Strand Conformation Polymorphism (SSCP) Analysis and SSCP-Hybrid Methods. Current Protocols in Human Genetics, N.C. Dracopoli, J.L. Haines, B.R. Korf. John Wiley and Sons, Inc., New York 1997; 7.4: 1–19
   Google Scholar
• Papp J., Csokay B., Zalay Z., , et al. Allele Loss from Large Regions of Chromosome 17 is Common Only in Certain Histological Subtypes of Ovarian Carcinomas. Br. J. Cancer 1996; 74: 1592–1597
   PubMed Web of Science ®Google Scholar
• Niwa K., Itoh M., Murase T., , et al. Alteration of P53 Gene in Ovarian Carcinoma: Clinicopathological Correlation and Prognostic Significance. Br. J. Cancer 1994; 70: 1191–1197
   PubMed Web of Science ®Google Scholar
• Levesque M.A., Katsaros D., Yu H., , et al. Mutant P53 Protein Overexpression is Associated with Poor Outcome in Patients with Well or Moderately Differentiated Ovarian Carcinoma. Cancer 1995; 75: 1327–1338
   Google Scholar
• Herod J.J., Eliopoulos A.G., Warwick J., , et al. The Prognostic Significance of Bcl-2 and P53 Expression in Ovarian Carcinoma. Cancer Res. 1996; 56: 2178–2184
   PubMed Web of Science ®Google Scholar
• Buttitta F., Marchetti A., Gadducci A., , et al. P53 Alterations are Predictive of Chemoresistance and Aggressiveness in Ovarian Carcinomas: a Molecular and Immunohistochemical Study. Br. J. Cancer 1997; 75: 230–235
   PubMed Web of Science ®Google Scholar
• Eltabbakh G.H., Belinson J.L., Kennedy A.W., , et al. P53 Overexpression is Not an Independent Prognostic Factor for Patients with Primary Ovarian Epithelial Cancer. Cancer 1997; 80: 892–898
   PubMed Web of Science ®Google Scholar
• Goff B.A., Muntz H.G., Greer B.E., , et al. Oncogene Expression: Long-term Compared with Short-Term Survival in Patients with Advanced Epithelial Ovarian Cancer. Obstet. Gynecol. 1998; 92: 88–93
   PubMed Web of Science ®Google Scholar
• Shibata D., Schaeffer J.L.Z.H., Capella G., , et al. Genetic Heterogeneity of the c-K-RAS Locus in Colorectal Adenomas but Not in Adenocarcinomas. J. Natl Cancer Inst. 1993; 85: 1058–1063
   PubMed Web of Science ®Google Scholar
• Howe J.R., Conlon K.C. The Molecular Genetics of Pancreatic Cancer. Surg. Oncol. 1997; 6: 1–18
   PubMed Web of Science ®Google Scholar